Veterinary Antibiotics Market, by Product Type (Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, and Others), by End Use (Dairy Farm, Poultry Farm, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

  • Published On : Dec 2018 |
  • Pages : 165 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Veterinary Antibiotics Market – Insights

Veterinary antibiotics combat infections caused by bacteria. Antibiotics are used for a variety of purposes in the farming of livestock, including therapeutic and prophylaxis or preventative treatment against a number of diseases. Antibiotics are also used in herds or flocks to promote growth. Antibiotic powders and tablets are fed to animals for increasing livestock production and nutritional level.

The global veterinary antibiotics market size was valued at US$ 1.2 billion in 2017, and is expected to witness a CAGR of 3.8% over the forecast period (2018 – 2026).

Global Animal Products Consumption (Kg Per Capita) 2015 & 2030

                                                         

Source: Food and Agriculture Organization

Increasing demand for meat and poultry is expected to drive the veterinary antibiotics market revenue

Increasing demand for livestock products including meat, milk, and other animal food products worldwide is expected to boost the veterinary antibiotics market growth. Moreover, increasing incidence of diseases in livestock is likely to aid in expansion of this market. According to the United Nations 2015 report, antibiotics consumption in livestock is expected to reach 105,600 tons by 2030, globally due to increases in the number of animals raised for food production.

Furthermore, in order to meet increasing demand for animal protein, majority of the farmers are transitioning to intensive agriculture and often use antibiotics to optimize production. According to the Organisation for Economic Co-operation and Development (OECD) 2015 data, with increase in human population and increased demand for meat, estimated antibiotic use in food animals will increase by 67% globally from 2010 to 2030.

Veterinary Antibiotics Market Restraints

Although antibiotics are important for treating infections, using antibiotics can lead to antibiotic-resistant infections in animals and humans consuming them. Factors such as side effects of antibiotics and stringent government regulations for antibiotics use in emerging economies are expected to hamper veterinary antibiotics market growth during the forecast period. According to the new guidelines published by the World Health Organization (WHO), in 2017, the farmers and the food industry is recommended to stop using antibiotics routinely to promote growth and prevent disease in healthy animals.

Veterinary antibiotics undergo a rigorous review process by the Food and Drug Administration (FDA), which approves all antibiotics used for food producing animals. All products approved by the FDA for use in food-producing animals must pass significant human- and food-safety benchmarks.

Furthermore, demand for organic livestock is another major factor restraining market growth. According to the U.S. Department of Agriculture National Agricultural Statistics Service (USDA NASS), the U.S. organic broiler chicken inventories grew 145% by 2016. This demand for organic products is attributed to increased consumer concern about health.

Veterinary Antibiotics Market - Regional Insights

On the basis of region, the global veterinary antibiotics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America held the largest revenue share of the global veterinary antibiotics market in 2017, owing to rising animal farming coupled with increasing expenditure on animal healthcare and growing demand for animal-derivative food products. According to the FDA 2014 report, of all antibiotics sold in the U.S., around 80% were sold for use in animal agriculture. As per the same source, in the U.S., the total amount of antibiotics used in food-producing animals increased by 16% between 2009 and 2012, to 14.61 million kilograms per year.

Asia Pacific veterinary antibiotics market is anticipated to grow at the highest growth rate, due to rising poultry, meat and dairy consumption, and rising awareness about animal health, especially in the emerging economies such as India. According to the study published in Plos Journal in 2016, the national diet of India has radically changed, with increased meat consumption among the young urban generation. This growing demand for animal proteins has resulted in intensive breeding of fish, poultry, and pigs with the routine use of antibiotics as growth promoters. Moreover, according to the Organization for Economic Co-operation and Development (OECD), China is the major producer of pork meat with around 31.3 kg/capita pork meat produced in 2016, followed by poultry and beef.

Global Veterinary Antibiotics Market Value (US$ Bn) & Y-o-Y Growth (%)

   

 Source: Coherent Market Insights Analysis (2018)

Veterinary Antibiotics Market - Competitive Landscape

Key players operating in the global veterinary antibiotics market include Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi, Vetoquinol S.A., Virbac, and Zoetis, Inc.

Antibiotics are used in livestock production to treat diseases in animals, to control infection of disease among healthy animals, to prevent disease in animals, and to increase animal productivity. Antibiotics keep poultry and livestock healthy, thereby reducing the chance of bacterial transmission from animals to humans. Majority of antibiotics drugs approved for use in food-producing animals through their feed or water are available over-the-counter.

Market Dynamics

Increasing demand for animal protein and growing demand for food production from animal source is leading driver for use of antibiotics in animal agriculture. Several countries across the world produce meat and aquaculture products. According to Organization for Economic Co-Operation and Development (OECD), an average U.S. adult consumed 198 pounds of meat in 2014. According to the WHO 2015 report, South East Asia region (SEAR) has developed intensive farming systems, leading to the rising consumption of fertilisers, antibiotics, and pesticides.

However, over-use and misuse of antibiotics in animals and humans is rising threat of antibiotic resistance. Therefore, governments across the globe are banning or limiting use of antibiotics in animal production and growth. For instance, in November 2018, European Union (EU) approved restrictions on Veterinary Antibiotics. The new legislation, which is expected to become law by 2022, bans use of antibiotics for animals, which are important for human medicine and prohibits use of any antimicrobials in livestock without a prescription from a veterinary doctor. In 2016, the United Nations General Assembly (UNGA) brought together the global community in declaring antimicrobial resistance (AMR) as a major concern and a global commitment to fight an issue through multi-pronged approaches.

Key features of the study:

  • This report provides in-depth analysis of the veterinary antibiotics market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2026, considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global veterinary antibiotics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi, Vetoquinol S.A., Virbac, and Zoetis, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global veterinary antibiotics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for veterinary antibiotics market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Veterinary Antibiotics Market, By Product Type:
    • Anti-parasitic
    • Anti-bacterial
    • Non-steroidal anti-inflammatory drug
    • Others
  • Global Veterinary Antibiotics Market, By End Use:
    • Dairy Farm
    • Poultry Farm
    • Others
  • Global Veterinary Antibiotics Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Product Type:
        • Anti-parasitic
        • Anti-bacterial
        • Non-steroidal anti-inflammatory drug
        • Others
      • By End Use:
        • Dairy Farm
        • Poultry Farm
        • Others
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Product Type:
        • Anti-parasitic
        • Anti-bacterial
        • Non-steroidal anti-inflammatory drug
        • Others
      • By End Use:
        • Dairy Farm
        • Poultry Farm
        • Others
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Product Type:
        • Anti-parasitic
        • Anti-bacterial
        • Non-steroidal anti-inflammatory drug
        • Others
      • By End Use:
        • Dairy Farm
        • Poultry Farm
        • Others
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Product Type:
        • Anti-parasitic
        • Anti-bacterial
        • Non-steroidal anti-inflammatory drug
        • Others
      • By End Use:
        • Dairy Farm
        • Poultry Farm
        • Others
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Product Type:
        • Anti-parasitic
        • Anti-bacterial
        • Non-steroidal anti-inflammatory drug
        • Others
      • By End Use:
        • Dairy Farm
        • Poultry Farm
        • Others
    • Africa
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
      • By Product Type:
        • Anti-parasitic
        • Anti-bacterial
        • Non-steroidal anti-inflammatory drug
        • Others
      • By End Use:
        • Dairy Farm
        • Poultry Farm
        • Others
  • Company Profiles
    • Bayer AG*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Boehringer Ingelheim GmbH
    • Ceva Sante Animale S.A.
    • Crystal Pharma
    • Dechra Pharmaceuticals PLC
    • Huvepharma AD
    • Eli Lilly Company
    • Merck & Co., Inc.
    • Sanofi S.A.
    • Vetoquinol S.A.
    • Virbac
    • Zoetis, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By End Use
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Landscape
    • Antibiotics Substitutes
    • Epidemiology Analysis
    • PEST Analysis
  4. Global Veterinary Antibiotics Market, By Product Type, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Anti-parasitic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Anti-bacterial
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Non-steroidal anti-inflammatory drug
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  5. Global Veterinary Antibiotics Market, By End Use, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Dairy Farm
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Poultry Farm
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Veterinary Antibiotics Market, By Region, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2016 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End Use, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End Use, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End Use, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End Use, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End Use, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End Use, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Bayer AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Boehringer Ingelheim GmbH
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Ceva Sante Animale S.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Crystal Pharma
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Dechra Pharmaceuticals PLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Huvepharma AD
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Eli Lilly Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Elanco
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Merck & Co., Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Vetoquinol S.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Virbac
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Zoetis, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
  8. Section
    • Analyst Views
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 23 market data tables and 18 figures on "Veterinary Antibiotics Market” - Global forecast to 2026”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.